J.T. Hartmann

Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study

Carsten Bokemeyer, Igor Bondarenko, J.T. Hartmann et al. · Annals of Oncology · 2011 · 778 citations · Full text

Biomarker Status, Oncology, Gastrointestinal Oncology +9

SSM/I Sea Ice Remote Sensing for Mesoscale Ocean-Atmosphere Interaction Analysis

Lars Kaleschke, Christof Lüpkes, Timo Vihma et al. · Canadian Journal of Remote Sensing · 2001 · 350 citations

Engineering, Radio Communication, Oceanography +23

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena et al. · Annals of Oncology · 2012 · 320 citations · Full text

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · Annals of Oncology · 2014 · 258 citations · Full text

Surgical Oncology, Hepatology, Gastrointestinal Oncology +10

KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience

Carsten Bokemeyer, Igor Bondarenko, J.T. Hartmann et al. · Journal of Clinical Oncology · 2008 · 241 citations

Kras Mutations, Surgical Oncology, Gastrointestinal Oncology +15